EVA Pharma is a global pharmaceutical company with over 100 years of healthcare heritage, operating in more than 60 countries and supported by advanced R&D capabilities and internationally accredited manufacturing facilities. Beyond our own product portfolio, we offer a comprehensive range of B2B partnership models, including Out-Licensing, Contract Manufacturing (CMO), Contract Development & Manufacturing (CDMO), and Co-Development opportunities. Leveraging our research centers, development expertise, and three regulatory-approved manufacturing facilities, we support partners across Europe and global markets in bringing high-quality, accessible medicines to patients worldwide.

Types of Drugs Manufactured
Small Molecule;Biologics;Nutraceuticals

CDMO Services
Drug Product/FDF;Research & Development;Packaging(Commercial);Regulatory Services;Analytical Development;Packaging (Clinical);Process & Forumulation Development;Supply Chain Logistics

Therapeutic Area
Cardiovascular;Central Nervous System;Hematology;Immunology;Infectious Disease;Musculoskeletal System;Nutritional;Oncology;Ophthalmology;Respiratory;Pain Symptoms

High Potent Products capabilities
OEB 4-5 Highly Potent APIs (HPAPIs)

Facilities Location
Middle East

Manufacturing Technologies
Blow-Fill-Seal (BFS);Cartridges;Inhalers;Lyophilized amps/vials;Pre-Filled Syringes (PFS);Soft Gels;Sterile Ampoules;Sterile Vials;Tablets/Capsules

Current Capacity
We have capacity in our 3 facilites, and willing to disclose this info upon request.